Anondita Medicare Ltd vs Manglam Infra Engineering Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anondita Medicare Ltd is ₹ 657 as of 23 Mar 15:30 . The P/E Ratio of Anondita Medicare Ltd is 0 as of March 2025 .The P/E Ratio of Manglam Infra & Engineering Ltd is 0 as of March 2025 . The Market Cap of Anondita Medicare Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Manglam Infra & Engineering Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Anondita Medicare Ltd is 0 % as of September 2023 .The Dividend Payout of Manglam Infra & Engineering Ltd is 0 % as of September 2023.

About Anondita Medicare Ltd

Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards. Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.

About Manglam Infra & Engineering Ltd

Manglam Infra & Engineering Ltd was originally formed as Partnership Firm in the name and style of 'Manglam Associates' pursuant to Partnership Deed dated February 17, 2010.
The Partnership Firm got converted into Public Limited Company 'Manglam Infra & Engineering Limited' on July 20, 2023, vide Certificate of Incorporation issued by Registrar of Companies, Central Registration Centre. Manglam Infra & Engineering are an infrastructure consultancy company, and their core business is providing project management consultancy services which includes detailed project reports (DPRs), Supervision and quality control (SQC), and operation & maintenance (O & M) for Highways/Roads, Bridges, Tunnels, Buildings/Urban development.
The Company undertake various project independently as well as through Joint ventures and MoUs with other players in this industry.

FAQs for the comparison of Anondita Medicare Ltd and Manglam Infra & Engineering Ltd

Which company has a larger market capitalization, Anondita Medicare Ltd or Manglam Infra & Engineering Ltd?

Market cap of Anondita Medicare Ltd is 1,231 Cr while Market cap of Manglam Infra & Engineering Ltd is 24 Cr

What are the key factors driving the stock performance of Anondita Medicare Ltd and Manglam Infra & Engineering Ltd?

The stock performance of Anondita Medicare Ltd and Manglam Infra & Engineering Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anondita Medicare Ltd and Manglam Infra & Engineering Ltd?

As of March 23, 2026, the Anondita Medicare Ltd stock price is INR ₹680.85. On the other hand, Manglam Infra & Engineering Ltd stock price is INR ₹13.65.

How do dividend payouts of Anondita Medicare Ltd and Manglam Infra & Engineering Ltd compare?

To compare the dividend payouts of Anondita Medicare Ltd and Manglam Infra & Engineering Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.